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ABSTRACT: Transcription factor p53 plays a critical role in
the cellular response to stress stimuli. We have seen that p53
dissociates selectively from various promoter sites as a result of
oxidation at long-range through DNA-mediated charge trans-
port (CT). Here, we examine this chemical oxidation and
determine the residues in p53 that are essential for oxidative
dissociation, focusing on the network of cysteine residues
adjacent to the DNA-binding site. Of the eight mutants studied,
only the C275S mutation shows decreased aﬃnity for the Gadd45 promoter site. However, both mutations C275S and C277S
result in substantial attenuation of oxidative dissociation, with C275S causing the most severe attenuation. Diﬀerential thiol
labeling was used to determine the oxidation states of cysteine residues within p53 after DNA-mediated oxidation. Reduced
cysteines were iodoacetamide-labeled, whereas oxidized cysteines participating in disulﬁde bonds were 13C2D2-iodoacetamide-
labeled. Intensities of respective iodoacetamide-modiﬁed peptide fragments were analyzed by mass spectrometry. A distinct shift
in peptide labeling toward 13C2D2-iodoacetamide-labeled cysteines is observed in oxidized samples, conﬁrming that chemical
oxidation of p53 occurs at long range. All observable cysteine residues trend toward the heavy label under conditions of DNA
CT, indicating the formation of multiple disulﬁde bonds among the cysteine network. On the basis of these data, it is proposed
that disulﬁde formation involving C275 is critical for inducing oxidative dissociation of p53 from DNA.
Transcription factor p53 is one of the most heavily studiedhuman proteins due to its marked prevalence of mutation
in human cancer. Over half of all human cancers display
mutations in the p53 gene, with the majority of these mutations
localized to the DNA-binding domain.1−3 Although much
research has been conducted on this protein and its many roles
within the cell, the precise mechanisms by which p53 senses
cellular stresses and inﬂuences cellular fate are still largely
unknown. We have previously shown that DNA-mediated
charge transport (CT) can sequence-selectively promote the
oxidative dissociation of p53 bound to DNA.4 Here, we
examine the mechanisms by which DNA-mediated oxidation is
sensed by p53 and how the resulting dissociation from DNA
occurs.
A major focus of our laboratory has been the characterization
of long-range CT through DNA.5−9 We have found that
oxidative damage to DNA can occur from a distance because of
the migration of electron holes through the π-stacked bases.
Ground-state CT has been observed to occur over 100 base
pairs (34 nm) through DNA.10 However, perturbations in the
intervening base pair stack, such as abasic sites and base
mismatches, severely attenuate DNA CT. In a cellular
environment, oxidative damage can occur by reactive oxygen
species attacking DNA, and we have found that oxidative DNA
damage can also occur from a distance in vivo.5,6,11 The one-
electron oxidation potential of guanine is the lowest of the
bases (+1.29 V), therefore making it the most readily oxidized
base.12−14 Thus, a known hallmark of DNA CT oxidation is the
formation of DNA damage products at 5′ guanines of guanine
doublets and triplets.15 However, certain amino acid functional
groups, such as the thiol group of cysteine, possess lower one-
electron oxidation potentials than guanine and could
thermodynamically be oxidized in DNA-bound proteins.
The chemistry of thiols located near the DNA base stack was
investigated to determine whether thiol redox chemistry could
be modulated via DNA CT. Electrochemistry experiments on a
graphite surface have shown that a disulﬁde incorporated into
the backbone of an oligonucleotide can be reduced to the
corresponding thiol groups by the application of negative
potential.16 Additionally, DNA CT induced by a distally bound
anthraquinone (AQ) photooxidant is able to promote oxidation
of neighboring thiol groups incorporated into the backbone of
an oligonucleotide, resulting in the formation of a disulﬁde
bond.17
An intriguing feature of p53, which binds DNA as a tetramer,
is that it contains nine highly conserved cysteine residues within
the DNA-binding domain.18 These cysteines are purported to
play a variety of roles, including tetramer formation, Zn2+
binding, and sequence-speciﬁc interaction with the p53
response element (Figure 1). The response element consensus
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motif is 5′-RRRCWWGYYY-3′, with R representing a purine, Y
representing a pyrimidine, and W representing either an
adenine or a thymine.18 The p53 consensus sequence contains
two response elements that may be separated up to 13 bases,
with one monomer of p53 binding to each quarter site (5′-
RRRCW-3′). Within each p53 monomer, three cysteine
residues (C176, C238, and C242) and one histidine (H179)
coordinate a zinc ion that is believed to be structurally
necessary for DNA binding.2,19−21 Located close to the Zn2+,
but not participating in metal binding, is C182. Closer to the
DNA−p53 interface are the remaining conserved residues of
interest: C124, C135, C141, C275, and C277. Nestled into the
major groove, C277 is capable of forming a hydrogen bond
within the purine region of the p53 response element quarter
site.20,21 C275 is located 7.0 Å away from C277, from sulfur
atom to sulfur atom. Residues C124, C135, and C141 are found
as a cluster situated deeper into the core of the DNA-binding
domain, with C275 being 7.0 Å away from C135. Chen and co-
workers have reported these residues as being reduced in their
structural characterizations of the p53 DNA-binding site;
however, disulﬁde formation is plausible based on the proximity
of these residues with respect to one another.20,21
One can imagine these conserved cysteine residues electroni-
cally coupling to promoter site DNA and playing a role in the
redox modulation of p53. A model of p53 oxidation in response
to DNA CT is illustrated in Figure 1. Oxidation of p53 is
initiated at a distance by the photoexcitation of AQ covalently
tethered to DNA, injecting an electron hole into the DNA base
stack.4 This oxidizing equivalent is then shuttled through the π-
stacked base pairs and localizes to sites of low redox potential. If
the electron hole localizes to a site to which protein is bound,
such as the p53 promoter site, then the hole can oxidize the
lower redox potential amino acid residues within close
proximity to the DNA. This oxidation of p53 leads to
dissociation from the DNA, ultimately altering gene regulation
in response to genomic stress while leaving the DNA
undamaged.22 Experiments using electrophoretic mobility
shift assays (EMSA) have determined that p53 responds
selectively to oxidation via DNA CT, causing the protein to
dissociate from various promoter sites. We have seen that the
location of guanine residues within a p53 promoter site dictates
whether DNA-bound p53 can be oxidized through DNA CT.22
This sequence selectivity in DNA-mediated oxidation of p53
indicates an element of control, causing oxidative dissociation
of p53 when bound to certain promoter sites but not to others.
This selectivity in response to DNA CT may correlate with the
biological regulation of genes controlled by p53 under
conditions of oxidative stress.
Several groups have worked to investigate the intricacies of
p53 oxidation at a molecular level, an area of which little
information is known after more than 30 years of research. The
idea of redox modulation of p53 ﬁrst arose in work showing
that p53 can bind promoter sites selectively under reducing
conditions but not under oxidizing conditions.23 More recently,
Fersht and co-workers investigated the reactivity of cysteine
residues by alkylation in an eﬀort to stabilize mutant p53
observed in cancer.24 Using nanospray ionization (nESI) mass
spectrometry, they determined that C141 and C124 react ﬁrst
with alkylating agents and are therefore the most reactive
cysteine residues, followed by C135, C182, and C277.
Langridge-Smith and co-workers have utilized top-down and
middle-down Fourier transform ion cyclotron resonance (FT
ICR) mass spectrometry to determine the reactivity of cysteine
residues within p53 oxidized by H2O2.
25 They determined that
C182 and C277 exhibit signiﬁcant modiﬁcation with N-
ethylmaleimide and were deemed to be the most reactive
residues. However, the high reactivity of these residues was
determined to be primarily due to their high solvent
accessibility, which may not be the dominant factor in DNA-
bound p53 oxidation in vivo. Work has also been done to map
oxidized cysteine residues in H2O2-treated p53 by nESI FT ICR
mass spectrometry.26 This work showed that oxidation of the
p53 core domain by H2O2 caused a loss of Zn
2+ binding within
p53, with corresponding formation of two disulﬁde bonds
among C176, C182, C238, and C242. Our laboratory found,
using MALDI-TOF mass spectrometry, that DNA-mediated
oxidation of p53 might proceed via formation of a disulﬁde
bond involving C141 and an undetermined second cysteine.4
Here, we continue to investigate p53 cysteine oxidation
promoted at a distance through DNA CT. Speciﬁcally, we aim
to resolve the interplay of cysteine oxidation within the p53
DNA-binding domain through the study of p53 mutants. Using
EMSA, we investigate the eﬀect of select p53 mutations on
DNA binding aﬃnity as well as the ability to undergo oxidative
dissociation from the Gadd45 promoter site. The Gadd45
promoter site was chosen since p53 is known to readily bind
Figure 1. Scheme of p53 oxidation through DNA-mediated charge transport. Oxidation is initiated by AQ excitation, causing it to abstract an
electron from DNA. This electron hole equilibrates among the π-stacked bases, ultimately localizing to a low redox potential guanine site. If the
trapped electron hole localizes to the DNA−p53 interface, then the bound p53 protein may be oxidized due to amino acids with lower one-electron
oxidation potentials than that of guanine. The oxidation of DNA-bound p53 causes the formation of a disulﬁde bond and leads to the dissociation
from DNA. The orange spheres represent the sulfur atoms of each cysteine residue within the p53 DNA-binding domain, making them candidates
for oxidation via DNA CT and subsequent disulﬁde formation. The DNA−p53 interface is examined in greater detail in the corresponding boxed
region to the right. This diagram depicts the nine conserved cysteine residues within a DNA-bound p53 monomer in relation to one another and the
DNA based on the 3KMD crystal structure.20
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this sequence and has been shown to dissociate upon oxidation
via DNA CT.4 To determine if oxidative dissociation of p53
occurs concurrently with disulﬁde bond formation and to probe
the speciﬁc residues involved, we employed a diﬀerential thiol
labeling technique targeting cysteine residue oxidation states
through the use of isotopically distinct iodoacetamide labels.
The sequentially labeled samples were proteolytically digested,
and labeled peptide fragment intensities were examined on a
QTRAP 6500 LC-MS/MS and directly compared. Through
this methodology, we are able to characterize the redox states of
individual cysteine residues and observe disulﬁde formation
within p53 oxidized at a distance through DNA CT.
■ EXPERIMENTAL PROCEDURES
Synthesis and Modiﬁcation of Oligonucleotides. DNA
was synthesized using standard solid-phase automated syn-
thesis, modiﬁed with anthraquinone (AQ), and radiolabeled as
described previously.22,27,28 The DNA used in the following
experiments contains the Gadd45 promoter site (underlined)
with a 12 base 5′ linker. Constructs both without photooxidant
(light control, LC) and with AQ were made. AQ: 5′-AQ-AAA
TCA GCA CTA CAG CAT GCT TAG ACA TGT TC-3′. LC:
5′-AAA TCA GCA CTA CAG CAT GCT TAG ACA TGT
TC-3′. Complement: 5′-GAA CAT GTC TAA GCA TGC
TGT AGT GCT GAT TT-3′.
Protein Preparation. The p53′ protein is a full-length
human p53 containing three stabilizing mutations: M133L,
V203A, and N268D.29 All subsequent mutants studied are in
addition to the p53′ mutations and incorporated by site-
directed mutagenesis (QuikChange II, Agilent), with resulting
sequences veriﬁed by Laragen (primer sequences are located in
Supporting Information Table 1). The p53′ protein and
subsequent mutants were puriﬁed as previously described.22,30
Electrophoretic Mobility Shift Assay of p53′ and
Mutants. For the determination of apparent KD’s for each
mutant, varied concentrations of each p53′ mutant were added
to 25 nM Gadd45 response element DNA in the presence of 5
μM competitor DNA duplex (5′-GGAAAAAAAAAAAAAAAA-
AAACC-3′) (IDT), 0.1% NP-40 (Surfact-Amps NP-40,
Thermo Scientiﬁc), and 0.1 mg/mL BSA in p53 buﬀer (20
mM Tris-HCl, pH 8.0, 20% glycerol, 100 mM KCl, 0.2 mM
EDTA). Samples were prepared at ambient temperature,
allowed to incubate for 20 min, and electrophoresed on a
10% TBE polyacrylamide native gel (Bio-Rad) in 0.5× TBE
buﬀer at 4 °C and 50 V for 1.5 h. DNA from the gel was
transferred to Amersham Hybond-N nucleotide blotting paper
(GE Healthcare) with a semidry electroblotter (Owl HEP-1)
for 1 h at 175 mA in transfer buﬀer (25 mM Tris-HCl, pH 8.5,
200 mM glycine, 10% methanol). The blots were exposed to a
phosphorimaging screen (GE Healthcare), imaged with a
STORM 820 or Typhoon FLA 9000 scanning system (GE
Healthcare), and analyzed using ImageQuant TL and Origin-
Pro.
Samples prepared for p53 oxidation assays contained 25 nM
p53 tetramer under the same conditions as those listed above
for the majority of the mutants. Two mutants were assayed at
higher p53 concentrations due to their higher apparent KD
values: Y236F-p53′ at 50 nM tetramer and C275S-p53′ at 125
nM tetramer. Samples were made at 4 °C and irradiated in an
ice bath for varying lengths of time (0, 5, 15, 30, 45, and 60
min) by solar simulator (ORIEL Instruments) with a UVB/
UVC long-pass ﬁlter. These samples were then analyzed by
EMSA as described above, and data were normalized to the
corresponding unirradiated control. The change in p53 binding
was determined by monitoring the free DNA signal over the
total DNA signal in each lane. Data are an average of a
minimum of three assay replicates, and the error is reported as
the standard error of the mean.
Selective Cysteine Labeling with Iodoacetamide Tags.
Proteins p53′, C275S-p53′, and C141S-p53′ were studied to
observe changes in cysteine oxidation state in DNA-bound p53
upon long-range DNA CT. Each sample consisted of 100 μL of
1.0 μM Gadd45 DNA (LC or AQ), 2.0 μM p53′ monomer,
0.1% NP-40, and 5.0 μM competitor DNA, in p53 buﬀer.
Samples were prepared at 4 °C and allowed to incubate for 20
min prior to aliquoting. Samples for irradiation were aliquoted
into a low-proﬁle 96-well PCR plate (Bio-Rad) at 10 μL each,
placed in an ice-water bath, and irradiated for 1 h by solar
simulator with a UVB/UVC long-pass ﬁlter. Unirradiated
samples remained in the dark at 4 °C for the duration of the
other irradiations. Samples were adjusted to 6 M guanidine
hydrochloride (GdmCl), by the addition of 8 M GdmCl in 20
mM Tris, 100 mM KCl, 0.2 mM EDTA, at pH 7.8. The
samples were transferred to Amicon Ultra 0.5 mL 30 kDa cutoﬀ
centrifugal ﬁlter units (Millipore) and centrifuged at 13 000g for
15 min. The concentrated samples, ∼30 μL, were then treated
with a 100-fold molar excess of iodoacetamide (single-use,
Thermo Scientiﬁc) with respect to the number of cysteine
residues present. The reaction was allowed to continue for 1 h
in the dark, shaking at 250 rpm. Samples were diluted with 6 M
GdmCl and centrifuged, repeatedly, until the concentration of
remaining iodoacetamide was at least 100-fold below the
number of cysteine residues and concentrated to ∼30 μL.
Dithiothreitol (DTT) was added at a 10-fold molar excess of
the reactive species present in the sample, cysteine, and
remaining iodoacetamide, to reduce disulﬁdes. This reduction
was allowed to incubate for 20 min at ambient temperature in
the dark, shaking at 250 rpm. The same molar concentration of
Tris(2-carboxyethyl)phosphine (TCEP-Neutral, Calbiochem)
as that of DTT was then added to further ensure disulﬁde
reduction and allowed to incubate, as above, for another 20
min. Samples were diluted with 6 M GdmCl and centrifuged,
repeatedly, until the concentration of remaining DTT and
TCEP were at a molar concentration 1000-fold below the
number of cysteine residues present and the total volume was
concentrated to ∼30 μL. To each sample was added 13C2D2-
iodoacetamide (Aldrich) in H2O at a 100-fold molar excess
with respect to the cysteine residues and remaining reducing
agents present. This reaction was allowed to continue for 4 h at
ambient temperature, shaking at 250 rpm, in the dark. The
samples were diluted using 100 mM Tris, pH 8.5, to decrease
the GdmCl concentration. The sample was repeatedly diluted
and centrifuged until the ﬁnal GdmCl concentration was below
0.1 M GdmCl in a ﬁnal sample volume of ∼30 μL and dried in
vacuo. The dry sample pellet was dissolved in 40 μL of 8 M urea
in 100 mM Tris-HCl, pH 8.5. One microliter of 0.1 μg/μL lysyl
endopeptidase (WAKO) dissolved in 100 mM Tris-HCl, pH
8.5, was added to each sample and allowed to incubate for 4 h
at ambient temperature in the dark. The samples were
subsequently diluted with 100 mM Tris-HCl, pH 8.5, to a
ﬁnal concentration of 2 M urea and adjusted to 1 mM CaCl2.
Trypsin (1 μL of 0.5 μg/μL) (Promega) in water was added to
each sample and allowed to incubate in the dark overnight at
ambient temperature. The following morning, each sample was
adjusted to 5% formic acid to simultaneously inhibit protease
activity and protonate tryptic peptides; samples were then dried
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in vacuo. Dry samples were suspended into 50 μL of 0.1% TFA
and sonicated for 5 min. Stagetips were made in-house with
Empore Extraction disk C-18 membranes (3M) for desalting
the peptide samples.31 The stagetip was washed once with 100
μL of 80% acetonitrile in 0.1% TFA and twice with 100 μL
0.1% TFA prior to sample loading, centrifuging for 3 min at
3000 rpm between each round. Samples were loaded to the
stagetip by centrifugation and then washed twice with 100 μL
of 0.1% TFA. The sample was eluted with 100 μL of 80%
acetonitrile in 0.1% TFA into a fresh collection tube. The
eluent was dried in vacuo and stored at −20 °C until analysis.
Multiple Reaction Monitoring (MRM) Mass Spectrom-
etry. Each protein sample, 500 fmol per injection, was
dissolved in 2% acetonitrile with 0.2% formic acid (FA). To
ensure consistency among sample sets and to help validate
proper peak assignment by retention time, iRT peptide
standards (BIOGNOSYS) were added. Samples were examined
on the ABSciex QTRAP 6500 LC-MS/MS system, equipped
with an Eksigent ekspert nanoLC 425 pump, ekspert
nanoLC400 autosampler, ekspert cHiPLC, and Analyst
software. Samples were separated on a cHiPLC Chrom XP
C18-CL 3 μm trap column, 120 Å (200 μm × 0.5 mm), inline
with a cHiPLC Chrom XP C18-CL 3 μm column, 120 Å (75
μm × 150 mm) using a 45 min linear gradient of acetonitrile in
0.2% FA at a ﬂow rate of 300 nL/min. An unscheduled
transition list of cysteine-containing peptides with both
respective iodoacetamide labels, as well as iRT peptide
standards, was generated by Skyline and exported to the
QTRAP for quantitation (Supporting Information Table 1).32
Raw data ﬁles generated by the QTRAP were imported back
into Skyline, where peak areas were then integrated and
exported for further processing. Observable and quantiﬁable
peptide fragments include the following: C124, [121, 132]
SVTCTYSPALNK; C135, [133, 138] LFCQLAK; C141, [140,
156] TCPVQLWVDSTPPPGTR; C182, [182, 196]
CSDSDGLAPPQHLIR; and C275 and C277, [274, 280]
VCACPGR. Two cysteine-containing peptide fragments were
unobservable in our methods due to unfavorable mass/charge
of the fragments: C176, [174, 180] RCPHHER; C229, C238,
and C242, [213, 248] HSVVVPYEPPEVGSDCTTIHYN-
YMCNSSCMGGMNRR. Various proteases were evaluated;
however, this large peptide fragment could not be further
cleaved given the inherent amino acid sequence of p53′.
■ RESULTS
Mutant p53′ Aﬃnity for the Gadd45 Promoter Site.
To understand the chemistry of p53 oxidation from a distance
through DNA CT, individual residues within the DNA-binding
domain were selectively mutated. We used a pseudo-wild-type
p53, termed p53′, that incorporates three stabilizing mutations
(M133L, V203A, and N268D) while remaining redox active.29
All other mutants studied were created by site-directed
mutagenesis of the p53′ plasmid. The following cysteine
residues were mutated to similarly sized but redox-inactive
serine: C124, C135, C141, C182, C275, and C277. Two other
mutations studied include Y236F and N239Y. These mutations
were chosen since they are within close proximity to the
cysteine residues in question and involve the addition or
deletion of a similarly redox-active tyrosine (+0.9 V).11 This
cohort of p53 mutants was studied by EMSA to determine if
any changes in binding aﬃnity to the Gadd45 promoter site
were evident without photooxidation.
Each mutant protein was evaluated by EMSA, and the
apparent KD values were determined using varied concen-
trations of the p53′ mutants in the presence of 25 nM Gadd45
DNA (LC or AQ) in p53 buﬀer with 5 μM competitor DNA,
0.1% NP-40, and 0.1 mg/mL BSA. The determined apparent
KD values are listed in Table 1. The majority of the chosen
mutations did not signiﬁcantly change the binding aﬃnity of
these proteins to the Gadd45 promoter site as compared to that
of p53′, with or without AQ. The baseline of binding aﬃnity is
shown by p53′ with KD values of 1.6 ± 0.6 nM and 2.4 ± 1.1
nM of p53 tetramer for LC and AQ, respectively. C124S-p53′,
C135S-p53′, C141S-p53′, and C277S-p53′ all share similar
values as that of p53′, with apparent KD values below 5 nM
p53′ tetramer. Two mutants exhibited a slight decrease in
aﬃnity, at 9.7 ± 4.3 nM (LC) and 8.2 ± 4.7 nM (AQ) tetramer
for Y236F-p53′ and 15.1 ± 1.8 nM (LC) and 13.7 ± 4.4 nM
(AQ) tetramer for C182S-p53′. Notably, the C275S-p53′
mutant displays severely attenuated aﬃnity for the Gadd45
promoter site with apparent KD values of 56 ± 13 nM (LC)
and 54 ± 8 nM (AQ).
Oxidative Dissociation of p53′ Mutants through DNA
CT. Additional EMSAs were employed to determine if any of
these mutations altered the ability of p53′ to oxidatively
dissociate from the Gadd45 promoter site. Changes in p53′
binding to the Gadd45 promoter site with respect to irradiation
time for each mutant were quantiﬁed, and the results are shown
in Figure 2. A representative EMSA autoradiogram is provided
in Supporting Information Figure 1. Most samples were
composed of 25 nM p53′ tetramer and 25 nM Gadd45 DNA
in the presence of 5 μM competitor DNA, 0.1% NP-40, and 0.1
mg/mL BSA in p53 buﬀer. Y236F-p53′ and C275S-p53′ were
assayed at higher protein concentrations, 50 nM tetramer and
125 nM tetramer, respectively, to ensure protein−DNA binding
due to their higher apparent KD values. The fraction change in
p53′ binding is determined as the free DNA signal divided by
the sum of the free DNA and p53-bound DNA signals,
normalized to the unirradiated control. Each mutant was
analyzed over a minimum of three replicates, with the error bars
reﬂecting the standard error of the mean. Previous experiments
with the same construct, although with an intervening
mismatch, showed an inhibition of oxidative dissociation,
Table 1. Relative Dissociation Constants of Mutant p53
Bound to the Gadd45 Promoter Site
mutant of
p53a
KD LC DNA (nM
tetramer)b
KD AQ DNA (nM
tetramer)b
p53′ 1.6 ± 0.6 2.4 ± 1.1
C124S 3.7 ± 0.5 4.29 ± 0.04
C135S 4.4 ± 2.8 3.1 ± 1.2
C141S 4.6 ± 1.2 3.7 ± 0.3
C182S 15.1 ± 1.8 13.7 ± 4.4
Y236F 9.7 ± 4.3 8.2 ± 4.7
N239Y 1.2 ± 0.4 1.0 ± 0.1
C275S 56 ± 13 54 ± 8
C277S 3.0 ± 0.8 2.3 ± 0.5
aAll mutants contain the stabilizing mutations M133L, V203A, and
N268D. bThe apparent KD of p53′ (in tetramer units) was determined
at 25 nM duplex, 5 μM dAdT, 0.1% NP-40, 0.1 mg/mL BSA in 20
mM Tris-HCl (pH 8.0), 20% glycerol, 100 mM KCl, and 0.2 mM
EDTA at ambient temperature, and the sample was electrophoresed at
50 V on a 10% polyacrylamide gel in 0.5× TBE at 4 °C.
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demonstrating that oxidation of p53 is DNA-mediated, as
opposed to involving a direct AQ−protein interaction.4
The behavior of p53′ is the standard to which each mutant is
compared in Figure 2. The EMSAs of p53′ oxidation reveal
minimal oxidative dissociation from the LC-Gadd45 DNA
(white), lacking the pendant AQ photooxidant. However, the
p53′ protein readily dissociated from the AQ-Gadd45 DNA
(black), with 31.0 ± 1.2% total p53′ dissociation upon 60 min
of irradiation. The LC-Gadd45 DNA samples across all of the
mutants behave similarly, with minimal dissociation upon
irradiation irrespective of additional mutations. As compared to
the p53′ protein, several mutants displayed a slight increase in
the amount of dissociation from the AQ-Gadd45 DNA upon
irradiation: C141S-p53′ (37.9 ± 2.7%), Y236F-p53′ (37.2 ±
2.3%), C135S-p53′ (34.0 ± 5.0%), and C124S-p53′ (33.4 ±
8.6%). Conversely, several mutants displayed a slight
attenuation in the oxidative dissociation of p53 upon
irradiation: C182S-p53′ (27.2 ± 3.0%), N239Y-p53′ (25.5 ±
0.9%), and C277S-p53′ (22.6 ± 2.9%). The most notable
diﬀerence is observed with C275S-p53′, which reaches a
maximum of only 13.3 ± 2.5% protein dissociation upon
irradiation and is not within error of any other mutant.
Analysis of Cysteine Oxidation in p53′ by Mass
Spectrometry. Using multiple reaction monitoring (MRM)
through sensitive analytical mass spectrometry, we directly
examined the formation of disulﬁde bonds within p53′ and
mutants from a distance through DNA CT. An overview of the
cysteine labeling protocol used to diﬀerentially label cysteine
residues within p53 respective to oxidation state is shown in
Figure 3. Using this methodology, one can distinguish whether
individual cysteine residues in the protein are participating in a
disulﬁde bond. After protein oxidation is induced from a
distance by irradiation of the AQ-DNA, the protein is
denatured in 6 M GdmCl and treated with iodoacetamide.
Reduced cysteine residues in p53′ will react with iodoacetamide
(red), whereas oxidized cysteine residues participating in
disulﬁde bonds remain chemically unavailable. Removal of
excess iodoacetamide and subsequent reduction of all disulﬁde
bonds allow for accessibility of the newly reduced cysteine
residue thiol groups to react with the isotopically heavy 13C2D2-
iodoacetamide (blue). The protein is then proteolytically
digested, desalted by C18 stagetip, and analyzed on a
QTRAP 6500 LC-MS/MS. Representative chromatograms of
the acquired data for the peptide fragment containing C124
from a p53′ sample set are shown at the bottom of Figure 3.
The peak areas for both the iodoacetamide (red) and 13C2D2-
iodoacetamide (blue) labeled fragments were analyzed in
Skyline and then directly compared.32 These data clearly show
the trend toward 13C2D2-iodoacetamide label with the AQL
sample, whereas controls (LCD, LCL, and AQD, see Figure 3)
were predominated by the isotopically light iodoacetamide
label.
Figure 2. EMSA analysis to determine the activity of mutant p53 bound to the Gadd45 promoter site upon distally induced DNA-mediated
oxidation. Solid markers represent AQ samples, and hollow markers represent LC samples. The data are representative of the average of a minimum
of three replicates, with the error given as the standard error of the mean. Samples contained 25 nM mutant p53′ tetramer and 25 nM Gadd45 DNA
in the presence of 5 μM competitor DNA, 0.1% NP-40, and 0.1 mg/mL BSA in p53 buﬀer (20 mM Tris-HCl, pH 8.0, 20% glycerol, 100 mM KCl,
and 0.2 mM EDTA). Two mutants were assayed at higher protein concentrations due to their higher apparent KD values: Y236F-p53′ at 50 nM
tetramer and C275S-p53′ at 125 nM tetramer.
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Proteins p53′, C275S-p53′, and C141S-p53′ were studied by
mass spectrometry to observe changes in cysteine oxidation in
DNA-bound p53′ promoted at a distance through DNA CT.
We monitored the changes of cysteine residues in p53′ as our
standard of comparison. We also examined C275S-p53′ since it
displayed the least oxidative dissociation by EMSA as well as
C141S-p53′ since C141 was previously implicated in potential
disulﬁde formation through DNA CT.4 The ﬂoating-bar plots
for each peptide fragment depict the fraction of the total signal
of heavy and light modiﬁed species, totaling 1.0 (Figure 4). The
fraction of 13C2D2-iodoacetamide-labeled species is represented
in positive values (black), and the fraction of iodoacetamide-
labeled species is represented in negative values (white). These
cumulative data sets are represented with individual protein
mutants located in rows and corresponding cysteine-containing
peptide fragments in columns. Each sample set per mutant is
composed of 4 variants, corresponding to DNA used (LC or
AQ) and irradiation (D-dark, L-light). The data represent the
average of three replicates for the C124, C135, C141, and C182
peptide fragments. The data for C275 and C277 represent the
average of two replicates. The error is represented as the
standard error of the mean. Peptide fragments corresponding to
C176, C229, C238, and C242 could not be observed due to an
unfavorable mass/charge ratio.
A shift toward increased 13C2D2-iodoacetamide labeling
indicates that the cysteine of interest has become oxidized
and is participating in a disulﬁde bond. For p53′ and C141S-
p53′ sample sets, the AQL samples show a marked increase in
13C2D2- iodoacetamide labeling over that of the LCD, LCL, and
AQD control samples. The protein p53′ does indeed undergo
chemical oxidation through DNA-mediated DNA CT. Interest-
ingly, the C275S-p53′ sample set depicts a diﬀerent interplay of
oxidation states than that observed for p53′ and C141S-p53′.
The overall baseline of 13C2D2-iodoacetamide corresponding to
the C135 and the C182 peptides is signiﬁcantly higher across all
four samples. The C124, C141, and C277 peptides in C275S-
p53′ behave more similarly to the other sample sets with a
distinct, albeit a less intense, increase in the AQL samples as
compared to the controls.
■ DISCUSSION
Although much work has been done to elucidate the redox-
dependent binding of p53 to diﬀerent promoter sites, relatively
little is known about the chemistry of p53 oxidation at a
molecular level. We are particularly interested in how the
protein may be coupled into a charge transport pathway with
DNA and how DNA-mediated oxidation of p53 may aﬀect the
aﬃnity of p53 for individual promoter sites. The conserved
cysteine residues not involved in Zn2+ binding are of particular
Figure 3. Procedure for diﬀerential thiol labeling of cysteine residues.
Examples of the labeling procedure are depicted for a fully reduced
protein (left) and its corresponding oxidized, disulﬁde containing
counterpart (right). After oxidation from a distance through DNA CT,
the protein sample is denatured in 6 M GdmCl and treated with
iodoacetamide. Cysteine residues in a reduced state will react with
iodoacetamide (red), whereas cysteine residues participating in
disulﬁde bonds remain chemically unavailable. Removal of excess
Figure 3. continued
iodoacetamide followed by reduction of all disulﬁde bonds allow for
accessibility of newly reduced thiol groups to react with the second
13C2D2-iodoacetamide label (blue). The protein is then proteolytically
digested, peptide fragments are analyzed on a QTRAP 6500 LC-MS/
MS, and peak areas are integrated in Skyline. Representative
chromatograms of the C124 containing SVTCTYSPALNK peptide
fragment from a p53′ sample set are shown as relative intensities of
iodoacetamide (red) and 13C2D2IAA (blue) peptides detected. The
four traces represent the following: LCD, light control dark; LCL, light
control light; AQD, anthraquinone dark; and AQL, anthraquinone
light.
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interest due to their biologically accessible oxidation potential,
close proximity to DNA, and ability to form disulﬁde bonds. In
our studies, we sought to determine the role of various cysteine
residues (C124, C135, C141, C182, C275, and C277) within
the DNA-binding domain of p53 through mutagenesis. The
cysteine-to-serine mutation was chosen since serine is
structurally similar to cysteine but does not contain the
redox-active sulfur atom. Two other mutations involving redox-
active tyrosine residues (Y236F and N239Y) were investigated
as well, as tyrosine has the same one-electron oxidation
potential as that of cysteine (+0.9 V), also making it accessible
to photooxidation by DNA-bound AQ.11
Eﬀect of Select Mutations on p53′ Binding Aﬃnity.
Each mutant of p53′ was ﬁrst evaluated by determining changes
in aﬃnity for the Gadd45 promoter site. All comparisons were
made against the observed aﬃnity of p53′ tetramer for Gadd45
DNA, which was determined to be 1.6 ± 0.6 nM and 2.4 ± 1.1
nM of tetramer for LC and AQ, respectively. The majority of
our chosen mutations did not signiﬁcantly alter the binding
aﬃnity of these proteins to the Gadd45 promoter site. C124S-
p53′, C135S-p53′, C141S-p53′, N239Y-p53′, and C277S-p53′
all share similar aﬃnities as that of p53′, with apparent KD
values below 5 nM p53′ tetramer, indicating that C124, C135,
C141, N239, and C277 do not play a signiﬁcant role in
modulating p53 binding aﬃnity to DNA. Y236F-p53′ and
C182S-p53′ both exhibited a slight decrease in aﬃnity, with
corresponding apparent KD values between 8 and 15 nM p53
tetramer. This indicates that the integrity of Y236 and C182
within the protein may contribute to binding aﬃnity through
necessary DNA−protein contacts or protein−protein inter-
actions in tetramer formation. Notably, the C275S-p53′ mutant
displays severely attenuated aﬃnity for the Gadd45 promoter
site with KD values of 56 ± 13 (LC) and 54 ± 8 nM (AQ). This
ﬁnding demonstrates that the integrity and likely positioning of
C275 are necessary for the high-aﬃnity binding of p53 to
promoter site DNA.
Eﬀect of Select Mutations on Oxidative Dissociation.
How do these mutations aﬀect the oxidative dissociation of
DNA-bound p53? The behavior of p53′ is the standard to
which each mutant was compared. For p53′, 31% p53′
dissociation is seen relative to controls after 60 min of
irradiation of DNA-tethered AQ. Oxidative dissociation from
the AQ-Gadd45 DNA is equal to or slightly increased for
C124S-p53′, C135S-p53′, C141S-p53′, and Y236F-p53′ upon
irradiation. Slightly increased dissociation suggests that the
integrity of these residues is not essential. In contrast, several
mutants did cause attenuation in oxidative dissociation. The
C182S-p53′ mutation appears to slightly decrease oxidative
dissociation. The N239Y-p53′ mutation also shows a slight
decrease in dissociation; since tyrosine has the same redox
potential as cysteine and is within close proximity of the DNA,
the added tyrosine residue may become oxidized, preventing
electron hole migration to other cysteine residues.11 Interest-
ingly, while known to be a stabilizing mutation within p53,
N239Y has been observed in colorectal cancer somatic cell
mutations.29,33,34 It is noteworthy that the C277-p53′ mutant
binds Gadd45 DNA with comparable aﬃnity as that of p53′ but
does not appear to dissociate as readily, at 22% and not within
error of p53′. This result indicates that C277 may be a
necessary element for the oxidative dissociation of p53, perhaps
through coupling into the DNA CT pathway and initiating
disulﬁde formation with the nearby C275. Indeed, the most
Figure 4. Determination of cysteine oxidation states by MRM mass spectrometry. Proteins p53′, C275S-p53′, and C141S-p53′ were studied to
observe changes in cysteine oxidation induced through DNA CT. Cumulative data are depicted with individual mutant proteins localized in rows and
the corresponding cysteine-containing peptide fragments in columns. The ﬂoating-bar plots for each peptide fragment are depicted as the fraction of
the total signal of both heavy and light modiﬁed species, totaling 1.0. The fraction of 13C2D2-iodoacetamide-labeled species is represented in positive
values (black), and the fraction of iodoacetamide-labeled species is represented in negative values (white). Each plot is composed of four samples:
LCD, light control dark; LCL, light control light; AQD, anthraquinone dark; and AQL, anthraquinone light. The value (white) located within the
AQL ﬂoating bar represents the percent change in heavy labeling of AQL sample with respect to the average of the corresponding LCD, LCL, and
AQD controls.
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signiﬁcant diﬀerence observed with the mutants is the severe
attenuation of oxidative dissociation of C275S-p53′, with a
maximum of only 13% dissociation. Thus, it is evident that
C275 plays a critical role in the aﬃnity of p53 for its promoter
site as well as enables oxidative dissociation. Interestingly, the
mutation of C275 has been observed in lung cancer.35 The
attenuation of oxidative dissociation in both C275S and C277S
suggests the possibility that these residues form a key disulﬁde
bond upon oxidation. The formation of a disulﬁde between
C275 and C277 would also remove DNA contacts, lowering
DNA aﬃnity overall, and enabling p53 dissociation. The
observed amounts of oxidative dissociation of C275S-p53′ and
C277S-p53′ are, however, not equal; this variation is likely due
to the diﬀering location of the cysteine residues with respect to
the DNA bases conveying the electron hole.
Mass Spectrometry Results to Characterize Cysteine
Oxidation States. Mass spectrometry studies were carried out
to understand the chemistry of DNA-mediated p53 oxidation.
A diﬀerential thiol labeling method was devised to determine
the oxidation state of speciﬁc cysteine residues within p53. The
sequential use of iodoacetamide, reducing agents, and isotopi-
cally distinct 13C2D2-iodoacetamide enable us to label cysteine
residues depending on their respective oxidation state. A shift
toward greater 13C2D2-iodoacetamide labeling in comparison to
that of controls, as monitored through MRM mass spectrom-
etry, indicates oxidation of that residue and its disulﬁde
participation. We were able to study six of the ten cysteine
residues present within the DNA-binding domain through this
technique. We were unable to detect C176 since it is located in
a very small and highly charged peptide fragment
[RCPHHER], resulting in an unfavorable mass/charge ratio.
Three cysteine residues (C229, C238, and C242), all residing
within one extraordinarily large peptide fragment [HSVVV-
PYEPPEVGSDCTTIHYNYMCNSSCMGGMNRR], could not
be further digested proteolytically and could therefore not be
detected within the limits of our instrumentation. The
remaining six cysteine residues are readily detected and
quantiﬁable. However, C275 and C277 reside within the
same peptide fragment, so secondary ion intensities were
utilized to deconvolute mixed species containing both
iodoacetamide and 13C2D2-iodoacetamide.
It is important to note that these mass spectrometry data
indicate directly that the DNA-bound p53′ protein can be
oxidized from a distance through DNA-mediated CT. Residues
bound to the DNA, and not those most accessible to solution,
are oxidized, funneling oxidative damage from the DNA helix
and into the protein. This DNA-mediated process promotes
p53′ dissociation from the Gadd45 promoter site.
The mass spectrometry data furthermore establish which
cysteine residues are being oxidized from a distance through
DNA CT. In most cysteine residues observed for both the p53′
and the C141S-p53′ sample sets, the AQL samples show a
marked increase in 13C2D2-iodoacetamide labeling samples as
compared to that of the LCD, LCL, and AQD controls. Thus,
cysteine oxidation resulting in disulﬁde bond formation is
occurring among all observable cysteine residues within p53′
and C141S-p53′. However, we are unable to determine whether
the disulﬁde formation is occurring intra- or intermolecularly
through our methodologies. Both p53′ and C141S-p53′ show
very similar proﬁles of oxidation with a signiﬁcant AQL-13C2D2-
iodoacetamide increase in all observable cysteine residues:
C124, C135, C141, C182, C275, and C277. It should be noted
that across all of the samples there is a baseline level of
oxidation, indicating some disulﬁde presence in the protein
prior to DNA CT. Nonetheless, it appears that the majority of
the cysteines are in the reduced state. Importantly, the fraction
of 13C2D2-iodoacetamide labeling is greatly increased upon
oxidation resulting from DNA CT. Removal of C141 through
the C141S mutation does not appear to alter the DNA binding
aﬃnity, oxidative dissociation, or the ability to oxidize any other
cysteine residues. This suggests that oxidation of C141 may
occur but that its presence is not necessary for modulation of
p53′ binding aﬃnity through DNA-mediated oxidation.
The C275S-p53′ sample set depicts a diﬀerent interplay of
oxidation states than that observed in either p53′ or C141S-
p53′, however. The overall baseline of 13C2D2-iodoacetamide
labeling for C135 and C182 peptide controls are high across all
four samples, greater than 60%, and show only a slight increase
in the AQL samples over the controls. The C124, C141, and
C277 peptides in C275S-p53′ behave more similarly to the
other sample sets with a distinct, albeit less intense, increase in
the AQL samples with respect to the controls. The smaller shift
toward 13C2D2-iodoacetamide labeling in the AQL samples
relative to the controls suggests that the absence of C275
disrupts the ability of oxidation to be transferred to the more
internal residues.
Oxidative Dissociation of p53′ by Disulﬁde Forma-
tion. By applying the observed data to the network of cysteine
residues within p53, we can consider how DNA-mediated
oxidation of p53 may occur and how it may lead to changes in
protein conformation that decrease aﬃnity for DNA. Reduced
p53 binds as a tetramer to the Gadd45 promoter site. Upon
DNA oxidation, an electron hole will migrate through the π-
stacked bases and localize to DNA sites of low redox potential,
such as guanine. This CT occurs on a time scale that is fast
compared to that of the irreversible reaction of guanine
radicals.36 In the case of the Gadd45 promoter site, the low
oxidation potential guanine sites are located within the purine
region of the consensus sequence in close proximity to p53
residue C277. Since the redox potential of cysteine (+0.9 V) is
lower than that of guanine (+1.29 V), the C277 residue tucked
in the major groove near guanine can accept the electron hole,
become oxidized, and lose its hydrogen bond to the major
groove of DNA.11−14 Due to the solvent accessibility of C277
and its close proximity to C275, further oxidation of C277 by
molecular oxygen would allow for loss of a second electron and
result in disulﬁde formation between C277 and C275, located
7.0 Å away. Disulﬁde formation between these two residues
would result in the loss of essential p53−DNA binding
contacts, leading to a signiﬁcant decrease in aﬃnity and
causing the dissociation of the oxidized p53 monomer.
Disulﬁde bonds are known to rearrange among other
cysteine residues within close proximity of one another within
proteins.37,38 Upon formation of the C277−C275 disulﬁde
bond, a subsequent rearrangement could occur given the
presence of many other reduced cysteine residues within close
proximity. If this were to occur, then C275 would most likely
form a disulﬁde with C135 (7 Å away). This bond
rearrangement would funnel the disulﬁde bond deeper into
the protein and enable C277 to become reduced and possibly
reestablish its H-bond to DNA. The disulﬁde bond could then
rearrange once more, resulting in one disulﬁde bond potentially
residing among the inner triad of cysteine residues: C124,
C135, and C141.
Thus, well-conserved cysteine residues of p53 provide a
chemical platform through which genomic oxidative stress can
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be directly sensed. Since p53 is a transcription factor presiding
over the regulation of hundreds of human genes, the oxidative
dissociation of p53 allows for a direct response in p53 gene
regulation during times of genomic stress. The extent of
oxidative dissociation of p53 depends on the DNA sequence of
the promoter site to which it is bound.22 Low redox potential
guanine bases located in the purine region of the p53 promoter
site allow for electron holes to localize at the DNA−protein
interface and to concomitantly oxidize p53. The variability of
bases within the promoter site, while fully conforming to the
consensus sequence constraints, allows for a tuning of the redox
potential at the DNA−protein interface. The DNA sequence of
the promoter site determines whether DNA-bound p53 will be
able to accept an electron hole and respond to genomic stress.
The cysteine residues in the protein create a network, which is
coupled to DNA, capable of accepting electron holes via DNA
CT. It is through p53 oxidation and disulﬁde formation that the
aﬃnity of p53 for DNA is decreased, leading to the observable
oxidative dissociation of DNA-bound p53.
These results thus indicate that DNA-mediated oxidation of
p53 is a chemically distinct mechanism for the cell to respond
speciﬁcally to oxidative damage to the genome. The oxidation
of p53 through DNA CT resulting in disulﬁde formation within
a protein is an exciting new chapter in the study of cellular
signaling of oxidative stress and the response of p53.
■ ASSOCIATED CONTENT
*S Supporting Information
Primer sequences used for site-directed mutagenesis, repre-
sentative p53 oxidation EMSA autoradiogram, and transition
list for the peptides monitored by the QTRAP 6500 LC-MS/
MS. This material is available free of charge via the Internet at
http://pubs.acs.org.
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: jkbarton@caltech.edu. Phone: (626) 395-6075.
Funding
This research was funded by the Ellison Foundation (AG-SS-
2079-08), the Moore Foundation for support of the Center for
Chemical Signaling at Caltech, the Gordon and Betty Moore
Foundation (GBMF775), The Beckman Institute, and National
Institutes of Health (1S10OD010788-01A1).
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
We thank Lisa Beckmann for assistance with molecular cloning
and protein puriﬁcation.
■ ABBREVIATIONS
p53′, full-length human p53 with stabilizing mutations M133L,
V203A, and N268D; CT, charge transport; AQ, anthraquinone;
LC, light control; EMSA, electrophoretic mobility shift assay;
GdmCl, guanidine hydrochloride; MRM, multiple reaction
monitoring; nESI, nanospray ionization; FT ICR, Fourier
transform ion cyclotron resonance
■ REFERENCES
(1) Paveletich, N. P., Chambers, K. A., and Pabo, C. O. (1993) The
DNA-binding domain of p53 contains the four conserved regions and
the major mutation hot spots. Genes Dev. 7, 2256−2564.
(2) Joerger, A. C., and Fersht, A. R. (2007) Structure−function-
rescue: the diverse nature of common p53 cancer mutants. Oncogene
26, 2226−2242.
(3) Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V.,
Hainaut, P., and Olivier, M. (2007) Impact of mutant p53 functional
properties on TP53 mutation patterns and tumor phenotype: lessons
from recent developments in the IARC TP53 database. Hum. Mutat.
28, 622−629.
(4) Augustyn, K. E., Merino, E., and Barton, J. K. (2007) A role for
DNA-mediated charge transport in regulating p53: oxidation of the
DNA-bound protein from a distance. Proc. Natl. Acad. Sci. U.S.A. 104,
18907−18912.
(5) Hall, D., Holmlin, R., and Barton, J. K. (1996) Oxidative DNA
damage through long-range electron transfer. Nature 382, 731−735.
(6) Delaney, S., and Barton, J. K. (2003) Long-range DNA charge
transport. J. Org. Chem. 68, 6475−6483.
(7) Muren, N. B., Olmon, E. D., and Barton, J. K. (2012) Solution,
surface, and single molecule platforms for the study of DNA-mediated
charge transport. Phys. Chem. Chem. Phys. 14, 13754−13771.
(8) Sontz, P. A., Muren, N. B., and Barton, J. K. (2012) DNA charge
transport for sensing and signaling. Acc. Chem. Res. 45, 1792−1800.
(9) Genereux, J., Boal, A., and Barton, J. K. (2010) DNA-mediated
charge transport in redox sensing and signaling. J. Am. Chem. Soc. 132,
891−905.
(10) Slinker, J., Muren, N., Renfew, S. E., and Barton, J. K. (2011)
DNA charge transport over 34 nm. Nat. Chem. 3, 228−233.
(11) Milligan, J. R., Tran, N. Q., Ly, A., and Ward, J. F. (2004)
Peptide repair of oxidative DNA damage. Biochemistry 43, 5102−5108.
(12) Steenken, S., Jovanovic, S. V., Bietti, M., and Bernhard, K.
(2000) The trap depth (in DNA) of 8-oxo-7,8-dihydro-2′deoxy-
guanosine as derived from electron-transfer equilibria in aqueous
solution. J. Am. Chem. Soc. 122, 2373−2374.
(13) Milligan, J. R., Aguilera, J. A., Nguyen, J. V., and Ward, J. F.
(2001) Redox reactivity of guanyl radicals in plasmid DNA. Int. J.
Radiat. Biol. 77, 281−293.
(14) Steenken, S., and Jovanovic, S. V. (1997) How easily oxidizable
is DNA? One electron reduction potentials of adenosine and
guanosine radicals in aqueous solution. J. Am. Chem. Soc. 119, 617−
618.
(15) Sugiyama, H., and Saito, I. (1996) Theoretical studies of GG
specific photocleavage of DNA via electron transfer: significant
lowering of ionization potential and 5′-localization of HOMO of
stacked GG bases in B-form DNA. J. Am. Chem. Soc. 118, 7063−7068.
(16) Gorodetsky, A. A., and Barton, J. K. (2007) DNA-mediated
electrochemistry of disulfides on graphite. J. Am. Chem. Soc. 129,
6074−6075.
(17) Takada, T., and Barton, J. K. (2005) DNA charge transport
leading to disulfide bond formation. J. Am. Chem. Soc. 127, 12204−
12205.
(18) El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and
Vogelstein, B. (1992) Definition of a consensus binding-site for p53.
Nat. Genet. 1, 45−49.
(19) Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. (1994)
Crystal structure of a p53 tumor suppressor−DNA complex:
understanding tumorigenic mutations. Science 265, 346−354.
(20) Chen, Y., Dey, R., and Chen, L. (2010) Crystal structure of the
p53 core domain bound to a full consensus site as a self-assembled
tetramer. Structure 18, 246−256.
(21) Chen, Y., Zhang, X., Dantas Machado, A. C., Ding, Y., Chen, Z.,
Qin, P. Z., Rohs, R., and Chen, L. (2013) Structure of p53 binding to
the BAX response element reveals DNA unwinding and compression
to accommodate base-pair insertion. Nucleic Acids Res. 41, 8368−8376.
(22) Schaefer, K. N., and Barton, J. K. (2014) DNA-mediated
oxidation of p53. Biochemistry 53, 3467−3475.
(23) Parks, D., Bolinger, R., and Mann, K. (1997) Redox state
regulates binding of p53 to sequence-specific DNA, but not to non-
specific or mismatched DNA. Nucleic Acids Res. 25, 1289−1295.
Biochemistry Article
DOI: 10.1021/bi501424v
Biochemistry 2015, 54, 932−941
940
(24) Kaar, J. L., Basse, N., Joerger, A. C., Stephens, E., Rutherford, T.
J., and Fersht, A. R. (2010) Stabilization of mutant p53 via alkylation
of cysteines and effects on DNA binding. Protein Sci. 19, 2267−2278.
(25) Scotcher, J., Clarke, D. J., Weidt, S. K., Mackay, C. L., Hupp, T.
R., Sadler, P. J., and Langridge-Smith, P. R. R. (2011) Identification of
two reactive cysteine residues in the tumor suppressor protein p53
using top-down FT ICR mass spectrometry. J. Am. Soc. Mass Spectrom.
22, 888−897.
(26) Scotcher, J., Clarke, D. J., Mackay, C. L., Hupp, T., Sadler, P. J.,
and Langridge-Smith, P. R. (2013) Redox regulation of tumour
suppressor protein p53: identification of the sites of hydrogen peroxide
oxidation and glutathionylation. Chem. Sci. 4, 1257−1269.
(27) Armitage, B., Yu, C., Devadoss, C., and Schuster, G. B. (1994)
Cationic anthraquinone derivatives as catalytic DNA photonucleases:
mechanisms for DNA-damage and quinone recycling. J. Am. Chem.
Soc. 116, 9847−9859.
(28) Gasper, S. M., and Schuster, G. B. (1997) Intramolecular
photoinduced electron transfer to anthraquinones linked to duplex
DNA: the effect of gaps and traps on long-range radical cation
migration. J. Am. Chem. Soc. 119, 12762−12771.
(29) Nikolova, P. V., Henckel, J., Lane, D. P., and Fersht, A. R.
(1998) Semirational design of active tumor suppressor p53 DNA
binding domain with enhanced stability. Proc. Natl. Acad. Sci. U.S.A. 95,
14675−14680.
(30) Veprintsev, D. B., Freund, S. M., Andreeva, A., Rutledge, S. E.,
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